I read that unfortunately Brazil stopped it's study after people died. More testing needs to be done, but with these complications I doubt it will be a quick fix.
The antimalarial is known to cause dangerous side-effects; even its relatively 'safer' cousin, hydroxychloroquine, doesn't have a great track record. Of particular concern is the risk for patients to develop serious heart problems.
After 11 patients died across both dosage groups, the team halted the high-dose arm of the trial on day six, citing more heart rhythm problems in the high-dose group, and "a trend toward higher lethality".
www.sciencealert.com
The antimalarial is known to cause dangerous side-effects; even its relatively 'safer' cousin, hydroxychloroquine, doesn't have a great track record. Of particular concern is the risk for patients to develop serious heart problems.
After 11 patients died across both dosage groups, the team halted the high-dose arm of the trial on day six, citing more heart rhythm problems in the high-dose group, and "a trend toward higher lethality".
![www.sciencealert.com](https://www.sciencealert.com/images/2020-04/processed/person_in_lab_holding_bottle_of_stuff_1024.jpg)
Study of High-Dose Chloroquine For COVID-19 Stopped Early Due to Patient Deaths
As the pandemic continues to rage across the globe, one potential treatment researchers are investigating for COVID-19 is the malaria drug chloroquine.
![www.sciencealert.com](https://www.sciencealert.com/images/2022/08/cropped-sa-rounded-favicon-32x32.png)